Infectious Diseases PRN Focus Session — “Out with the Old, In with the New?” The Role and Place in Therapy for Newly Approved Agents in Infectious Diseases
Monday, October 14, 2024 from 3:30 PM to 5:00 PM MST
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-131-L01
Activity Type: A Knowledge-Based Activity
The Infectious Disease PRN Programming Committee presents an education session focused on updates in novel ID agents and their place in practice. Specific areas of focus for this session include: 1) Management of Multi-Drug Resistant Gram-Negative Bacterial Infections: Which New Agents to Use 2) New Vaccine Considerations and Prevention Strategies for Viral Infections in the Inpatient and Outpatient Settings 3) Novel Antifungals and Their Place in Therapy. The target audience of this session is pharmacists practicing in all areas including, but not limited to, infectious disease pharmacists, clinical staff pharmacists, community pharmacy, pharmacy students, residents, fellows, and administrators. The purpose of this session is to identify practice areas where pharmacists can assist clinicians with new management approaches to common infections to optimize clinical outcomes using the most cost-effective options.
Faculty
 | | Moderator: | Radhika S. Polisetty, Pharm.D., FIDSA, BCIDP, AAHIVP |
|
Learning Objectives
1. List common mechanisms of Gram negative organism resistance that are addressed by novel antibiotics.
2. Select an appropriate antibiotic regimen, including novel agents, for multidrug resistant Gram negative organism(s).
3. Describe available immunizations for respiratory syncytial virus (RSV) and Streptococcus pneumoniae.
4. Review current CDC guidance in the appropriate selection of immunizations for RSV and Streptococcus pneumoniae.
5. Discuss the mechanisms of action, pharmacokinetics, and therapeutic indications of novel antifungal agents, focusing on their implications for antifungal resistance.
6. Identify clinical scenarios where novel antifungal agents offer efficacy or safety advantages over established treatments.
Management of Multi-Drug Resistant Gram-Negative Bacterial Infections: Which New Agents to Use3:30 PM to 4:00 PM  | | Speaker: | Ashlan Joy Kunz Coyne, Pharm.D. |
|
|
New Vaccine Considerations for Inpatient and Outpatient Settings4:00 PM to 4:30 PM | | Speaker: | Jessica M. Leininger, Pharm.D., MBA, BCIDP |
|
|
Novel Antifungals and Their Place in Therapy4:30 PM to 5:00 PM  | | Speaker: | Emily Drwiega, Pharm.D., BCIDP, BCPS | |
Visiting Clinical Assistant Professor of Pharmacy Practice, Clinical Pharmacist
Section of Infectious Diseases Pharmacotherapy, Department of Pharmacy Practice
University of Illinois at Chicago, College of Pharmacy | | View Biography |
|
|